The present disclosure relates to in vivo, quantitative methods for characterization of the transparency of a living eye lens, and to methods and apparatus that can track localized changes in the lens transparency from the age of 25 to 55 years. More particularly, the present disclosure relates to integrated fiber optic based dynamic light scattering apparatus and methods including an electronic processing system for the characterization of the physical properties of the lens through a measurement of the cross/auto correlation function of the backscattered signal from a focused beam of coherent radiation in the lens.
Generally, dynamic light scattering (DLS) aka photon correlation spectroscopy or quasi-elastic light scattering, refers to a sensitive method that provides for coherent illumination of an unknown system of scatterers in motion, and the coherent detection of the modulation resulting from the motion, and the subsequent analysis of the modulated signal, leading to the recovery of physical parameters characterizing the motion or the size, shape and speed of the scattering species.
U.S. Pat. No. 5,284,149 discloses the use of DLS for in vitro measurements from excised lenses from both animals and humans, but the non-imaging design of the backscatter fiber optic probe was not suitable for in vivo measurement of the human eye lens. U.S. Pat. No. 5,815,611 discloses an imaging backscatter fiber optic probe, which enables in vivo DLS measurements of the eye, see, “In vivo dynamic light scattering characterization of a human lens: cataract index,” Current Eye Research, vol. 20, No. 6, pp. 502-510 (2000). U.S. Pat. No. 5,973,779 discloses another imaging backscatter probe for in vivo DLS of the human eye. Ansari, R. R., et al., “Measuring Lens Opacity: Combining Quasi-Elastic Light Scattering with Scheimpflug Imaging System,” Proceedings of SPIE, 3246: 35-42 (1999). However, these ophthalmic systems have shortcomings in reliability and repeatability due to abnormalities arising from reflex and blinking by human subjects, as well as, obtaining a consistent measure of the progressing molecular changes taking place in the aging lens.
U.S. Pat. No. 5,706,072 discloses an ophthalmic measuring apparatus based on DLS. The apparatus includes an optical detecting system for detecting and excluding abnormalities in the scattered light intensity by means of photosensors and electronic shutters. However, the abnormality detection system is too slow to detect and exclude abnormalities in scattered light at the high-speed sampling times scales of 10 ns to 500 ns. The inherent latency in the detection and operation of the electronic shutters is of the order of milliseconds.
U.S. Pat. No. 7,236,250 discloses a DLS method based on phase-modulation and interference. Generally, phase-modulation methods, using homodyne detection, require substantially more components, as well as stabilized optical platforms for obtaining data of sufficiently high quality.
U.S. Pat. No. 8,467,067 discloses the use of DLS to extract the size of particles below 100 nm. The system is based on the use of low-coherence sources and path-length-resolved dynamic light scattering. While the technique has some utility in concentrated systems, however, it also requires a very stable optical platform to perform the heterodyne signal detection needed. These severe limitations make DLS methods based on phase-modulation unusable for in vivo ophthalmic applications.
U.S. Pat. No. 8,388,134 discloses a method and apparatus for performing quasi-elastic light scattering and fluorescent ligand scanning on a subject's eye. While also suffering from the above limitations the apparatus performs DLS at a scattering angle of 90°, restricting measurements to a central region of the lens, along the optical axis.
In addition to the technological limitations of the above methods, a reliable and quantifiable measure of the clarity (or lack of clarity) of the lens is still lacking.
The ophthalmic diagnostic systems and methods of this disclosure overcome the above short comings and provides a real-time measurement of the clarity of the lens through a single quantifiable parameter, Laser Crystallin Index (LCX), which shows measurable changes at least in the age group from 35 years to 55 years, see, Abazari, A, and Dhadwal H, “Utility of Vision Index Pen in detecting early cataract and loss of accommodation,” Abstract 6016 2018 ARVO Annual Meeting, Apr. 29, 2018, Honolulu, Hi. In addition to the technological advantages of the present disclosure, the apparatus and methods herein disclosed also decrease the costs of the ophthalmic device compared with prior systems, which use costly digital correlators.
It is an object of the present disclosure to provide an in vivo ophthalmic diagnostic apparatus for determining the lens crystallin aggregation index in the eye.
It is another object of the present disclosure to provide hardware for directly recovering the lens crystallin index from the auto/cross-correlation of the backward scattered laser light.
It is another object of the present disclosure to provide a hardware abnormal count sensor and discriminator.
It is another object of the present disclosure to provide a portable, relatively inexpensive apparatus for the lens crystallin index, and a fiber optic transreceiver for use in such an apparatus.
It is another object of the present disclosure to provide a hardware laser diode driver circuit breaker for added operational safety.
It is another object of the present disclosure to provide a field programmable gate array correlator and a math processor to have a low cost portable device.
A Vision Index Pen diagnostic system of the present disclosure, as well as other embodiments, objects, features and advantages of the present disclosure will be apparent from the following detailed description, which is to be read in connection with the accompanying drawings. It is to be understood, however, that the drawings are designed as an illustration only and not as a definition of the limits of this disclosure.
Provided in accordance with aspects of the present disclosure is a system for dynamic light scattering measurement provided in accordance with the present disclosure includes first and second light sources, first and second gradient index lenses, first and second optical paths from the first and second light sources to an eye by way of the first and second gradient index lenses, respectively, an optical splitter configured to split light, originating from the first and second light sources and scattered from the eye, into first and second light signals, first and second light detectors configured to detect the first and second light signals, respectively, and a correlator configured to correlate respective first and second signals output from the first and second light detectors.
In an aspect of the present disclosure, the first and second light sources are configured to produce different wavelengths of light.
In another aspect of the present disclosure, the correlator is a cross-correlator.
In yet another aspect of the present disclosure, the correlator is an FPGA autocorrelator.
In still another aspect of the present disclosure, the correlator includes an abnormal count sensor and discriminator configured to reject counter values falling outside a specified range to inhibit distortion of measurement.
In still yet another aspect of the present disclosure, first and second single-mode optical fibers are configured to define a portion of the first and second optical paths, respectively. In such aspects, the first and second single-mode optical fibers and the respective first and second gradient lenses may be incorporated into respective first and second transreceivers extending through a body of an eye probe.
In another aspect of the present disclosure, a circuit breaker is configured to shut down at least the first light source if emitted optical power from the first light source reaches a threshold.
A method for extracting a lens crystallin index and non-transitory computer readable medium having stored thereon instructions which, when executed by one or more processors, perform the method for extracting a lens crystallin index include obtaining measurements of backscattered light originating from a plurality of light sources and reflected by an eye, performing a data inversion of at least some of the obtained measurements to obtain inverted data, performing a fitting of at least some of the inverted data, and generating a lens crystallin index data plot based on a result of the fitting.
In an aspect of the present disclosure, obtaining measurements includes splitting the backscattered light into a plurality of light signals, detecting the plurality of light signals, and correlating the plurality of light signals to determine a counter value, wherein the obtained measurements are counter values.
In another aspect of the present disclosure, at least some of the obtained measurements are discarded and not used in the data inversion. In such aspects, obtained measurements within a counter value range are used in the data inversion and obtained measurements outside of the counter value range are not used in the data inversion.
In yet another aspect of the present disclosure, at least some of the inverted data is not used in the fitting. In such aspects, the inverted data at or below an upper limit is used in the fitting and the inverted data above the upper limit is not used in the fitting.
The above and other objects, features, and advantages of certain embodiments of the present invention will be more apparent from the following detailed description taken in conjunction with the accompanying drawings, in which:
While the presently disclosed apparatus and methods for determining the lens crystallin aggregation index may have utility for characterizing the transparency of the human eye lens, may additionally or alternatively have utility in determining the state of aggregation of other systems containing small molecules, such as aggregation of proteins during the synthesis of large single crystal proteins. As another example of a utility of the presently disclosed apparatus and methods, the state of aggregation of small molecules in the formulation of ophthalmic drugs may be determined. Thus, without limiting the applicability of the presently disclosed apparatus and methods to determining the lens crystallin aggregation index of the eye lens, the present disclosure detailed below provides exemplary embodiments with regard to determining the lens crystallin index of the eye lens.
Referring to
According to
The eye probe 1 is positioned in front of the eye 5 as shown in
The tether cable 2 is a strengthened, flexible steel tube with a black PVC coating. It shrouds three single-mode optical fibers 13, 14, 15, of which single-mode optical fibers 13, 14 deliver coherent signal beams to the eye probe 1 and single-mode optical fiber 15 collects the back scattered signal from the measurement volume 9. The proximal end portion 16 of the tether is fixed into a bushing 17 which is fastened to the front panel 18 of the enclosure of the electronic module 3, which houses the electronics and other devices. The proximal end portion of each of the single-mode optical fibers 13, 14, 15, is terminated with a connector, such as, FC/PC fiber optic connector. The connectorized single-mode optical fiber 13 is connected to one output arm of a 1×2 single-mode fiber optic power splitter 19, with a power splitting ratio 99:1. The input arm of the said 1×2 fiber optic coupler is connected to a variable optical attenuator 20. The second output arm 21 of the said 1×2 fiber optic coupler is connected to the input of the LD1 circuit breaker 22. The second single-mode optical fiber 14 is connected to an in-line FC/PC adapter 23. The third single-mode optical fiber 15 is connected to an in-line FC/PC adapter 24.
Software running on computer 4 or similar device controls the functioning of the VIPox system and guides the operator to make real-time, in vivo, measurements of the LCX in the measurement volume 9 of the lens 6. A microcontroller 25 receives instructions from the computer 4 and sends and receives signals from the various electronic devices mounted inside the enclosure of the electronics module 3. The primary coherent source 26 is driven from signals received from the driver board 27 which receives control signals from the microcontroller 25. Furthermore, the primary coherent source 26 is operated at constant temperature by means of a closed-loop temperature controller circuit 28. Temperature controller maintains the output signal power and spectral emission within the specified design limits of power and frequency of emission. A secondary coherent source 29 is driven from signals received from the driver board 30 which, in turn, receives control signals from the microcontroller 25.
The primary coherent source 26 is operated at two discrete power levels: a low power mode is used during the alignment step and a high-power mode is used during measurement. Secondary control of the optical power levels entering the lens 6 via the variable optical attenuators 20 and 23 enables the coherent sources 26 and 29 to be driven aggressively, ensuring spectral purity and power stability of the said sources. Spectral purity is directly proportional to the coherence length of the source, which increases the self-beating efficiency of the scattered signal, producing a correlation function of high signal quality. Further, the variable optical attenuator 20 is adjusted to ensure that the coherent source power level entering the lens 6 remains below the threshold power level for non-specific risk to the human eye 5. Direct current control of the coherent source 26 to achieve the eye-safe power levels is not desirable as this necessitates operation of the coherent source 26 near lasing threshold, resulting in poor spectral purity of the source emission and a correlation function of poor quality.
A further safety feature, LD1 circuit breaker 22, provides a control signal for immediate shut-down of the coherent source 26 if the emitted optical power level increases beyond the non-specific risk threshold. Here, circuit breaker 22 is implemented in hardware; however, software-based safety is also contemplated. The electronic circuit including circuit breaker 22 is designed to sense unpredictable increases in the optical power levels beyond a specified threshold and immediately turn off electrical power to the coherent source 26. The second output arm 21 of the 1×2 single-mode fiber optic power splitter 19, with a power splitting ratio of 99:1, collects 1% of the optical power entering the single-mode optical fiber 13. The LD1 circuit breaker 22, described below with reference to
The secondary coherent source 29, driven by the driver 30 with signals issued from the microcontroller 25, is used during the alignment to visualize the measurement volume 9 in the interior of the lens 6 and as a fixation target during the data acquisition period. The output signals from the primary and secondary sources are transported through single-mode optical fibers 34 and 35, the in-line optical attenuators 20 and 24, and the tether cable 2, until they emerge from the distal tip of the eye probe 1, as two angled, converging beams 7 and 8, with a common-cross over region or measurement volume 9 inside the lens 6.
The backward scatterred signal from the lens 6 cytoplasm, within the measurement volume 9, is collected along the coherent optical path 12. The collected signal is transported by the single-mode fiber 15 in the tether 2 to the input arm 36 of a 1×2 single-mode optical power splitter 37, which divides the signal emanating from the single-mode fiber 15 into two equal portions which are coupled to two single-mode optical fibers 38 and 39. Single photon counting modules 40 and 41 convert the optical signal to voltage pulses 42 and 43 of equal height and width, but with varying frequency. Dependent on the strength of the optical signal, pulse frequency increases with the increasing signal power. The asynchronous voltage pulses 42 and 43 are coupled to two inputs 44 and 45, respectively, of a digital correlator 46. The digital correlator 46 is configured to measure the real time cross-correlation of the two voltage signals 42 and 43, or the autocorrelation of either one of the voltage signals 42 and 43. Cross-correlation cancels the dead-time effects of single photon counting modules 40 and 41, thereby extending the high-speed response of the system. The start/stop functions of the digital correlator 46 are issued from the control program running on the computer 4 via signal wire 47, terminated with RJ45 connectors 48 (or the like). A speaker 49 emits an audible beeping sound (or other suitable audible output) during the measurement cycle informing the patient to remain stationary, with minimal eye and head movement. When the measurement terminates, the audible beeping sound stops indicating that the patient can relax. Subsequently, the data from the digital correlator 46 is transferred to the computer 4 for real-time analysis and data processing to recover the LCX value.
During an eye examination, a fixation target is typically used to direct the attention of the patient in a desired direction, allowing the optician to access various components of the eye 5. In the VIPDx system, use of externally mounted fixation targets, as is common in commercial slit lamps, is not effective as such a target cannot be placed directly along the optical axis of the eye 5. In the embodiment of
The VIPDx system uses a focused coherent source to interrogate the molecular composition of the eye lens 6. The device uses three safe-guards for safe operation below the exposure limit standards imposed by “ANSI Z80.36-2016 for Ophthalmics—Light Hazard Protection for Ophthalmic Instruments.” Referring back to
During normal operation, the voltage (VA) at the inverting input 84 of the comparator 85 is below the threshold voltage (VT) at the non-inverting input 86. Under this condition the output 88 of the comparator is at HIGH voltage level. As such, the PWR_EN 89 is also HIGH such that the output state 90 of the NAND gate 91 is LOW. The clock input 92 of the JK flip-flop 93 is also LOW. The output Q 94 of the JK flip-flop 93 is low, thus the fault indicator LED 95 is OFF. The resistor (R4) 96 limits the brightness of the LED 95. The complimentary output \Q 97 of the JK flip-flop 93 is HIGH. A HIGH level at the control input (D) 98 of the high side switch (HSW) 99 closes the switch, connecting voltage source (5VD) 100 to the output 101 of the high side switch 99, which is connected to the input (E) 102 of the power distribution block 103. One of the output power rails 104 supplies power to the laser diode driver 27 driving the primary coherent source driver 26 (see also
The circuit breaker 22 is triggered if the voltage (VA) at the inverting input 84 of the comparator 85 exceeds the threshold voltage (VT) at the non-inverting input 86 of the comparator 85. When the voltage (VA) exceeds the threshold voltage (VT), the output of the comparator 88 goes from HIGH to LOW, causing the clock input 92 of the JK flip flop 93 to go from LOW to HIGH causing the output (Q) 94 to go HIGH, turning the fault LED 95 ON. The complimentary output /Q 97 goes LOW causing the high side switch 99 to OPEN. The power to the LDD1 driver 24 is immediately turned OFF, resulting in a rapid SHUTDOWN of the primary coherent source 26. Recovery from the triggered circuit breaker 22 requires a hardware restart.
Referring to
Next, as indicated at 108 the patient is informed to remain still while the measurement is underway and eye probe 1 is locked into position. Thereafter, as indicated at 109, the MEASURE button on the interactive display is activated by the operator. The output signal power of the primary coherent source LD126 in
The average backward scattered signal count rate <n> should be within a predetermined range, for example, <n> must be within the range of 25 thousand counts per second to 1 million counts per second; and
The self-beating efficiency factor β, for dynamic light scattering should be within a predetermined range, for example, β must be greater than 0.5 and less than 1.0.
If the measured correlation function fails either of the two validation tests above, the measurement can either be repeated by starting back at 105 or the measurements for the patient can be aborted at 111. If the data is determined to be valid, a real-time non-linear least squares curve-fit to the measured correlation data is performed at 112 to recover a numerical estimate of the average lens crystallin index (LCX_1) and its standard deviation (LCX_2). The entries in the running data table on the interactive display is then updated at 106 with the latest numerical estimates. Typically, three to five independent measurements are taken at each measurement volume 9 (
The alignment procedure, Step 2 in
As illustrated in
The utility of the VIPDx system was established through an observational clinical trial, the results of which are summarized in
Another embodiment of the VIPDx system is illustrated in
Dynamic light scattering from weakly scattering systems requires the use of single photon detection followed by a digital correlator, as described in
where np is the number of pulses in the pth sample interval and m is the mth delay time increment corresponding to τm, Ns corresponds to the total number of sample intervals during the measurement. Unbiased inversion of the correlation function requires an unbiased estimate of the true baseline, which refers to the uncorrelated value defined at infinite delay time. One estimate referred to as the measured baseline allocates a group of delay channels at large delays compared with the sampling time. A calculated base line is estimated from the average count rate per sampling interval. Herein, the baseline is estimated using a running counter for total counts, that is,
The second order correlation function G(τ) is related to the first order correlation function g(τ), through the Siegert relation,
G(τ)=G∞[1+β|g(τ)|2] (Equation 3)
where β is the self-beating efficiency factor, typically, in the range 0.5 to 1.0, and G∞, is the baseline. Some data inversion techniques require the recovery of the first order correlation function while others use the second order function as it is measured. The physical information of the scattering system is embedded in the definition of the first order correlator function. As an example, the first order electric field correlation function is related to a distribution G(F), representing the weighted contribution of the characteristic decay rates F, through an integral relationship,
β1/2|g(τ)=∫ΓminΓmaxG(Γ)e−ΓτdΓ (Equation 4)
Derivation of equation (4) assumes an independent scattering system, with scatterers executing Brownian motion. The former assumption applies to low concentration systems, typically below 0.01% by weight. It should be noted that the lens cytoplasm has a protein concentration exceeding 35% by weight. Further, for Brownian motion F is a function of the scattering angle, refractive index and viscosity of the medium hosting the moving scatterers, the effective hydrodynamic radius of the scatterers, and wavelength of the coherent source. In general, large values of F correspond to fast moving components while small values correspond to slow moving components. Several methods are available for inverting the integral equation (4) for extracting G(F), and from that the distribution of hydrodynamic radius, or distribution of molecular weights.
Data inversion of the in vivo measurements from the lens cytoplasm has proven to be very challenging due to the high concentration of proteins in the lens as well as the degradation in the quality of the correlation function due to involuntary movement of the patient, such as blinking. Thus, it is prudent and necessary to extract as few parameters as possible from the measured correlation data. For this reason, a method based on cumulants expansion of the basis function in equation (4) is preferred for inverting measured correlation data. A linear approximation to equation (4) is,
where κI defined as the ith cumulant, and
The mean square error between the model, equation (5) and the normalized data equation (6), is given by,
where Pi are the unknown parameters to be determined from the data. The minimization constraint of equation (7) leads to a set of linear equations which can be solved to obtain the best estimates of Pis. It is common practice to use software algorithms to directly solve equation (7). However, the present invention describes a hardware solution which can be implemented using field programmable gate arrays (FPGA). The following equations are developed to extract P1, P2, and P3.
where M is the number of data points in the correlation function or the length of the normalized vector [bm], and the q1,2,3 and S1,2,3,4 are various summations given by,
where σΓ is the standard deviation of distribution G(Γ) with average value
Another difficulty encountered with in vivo DLS measurements is the momentary increases or decreases in the instantaneous counts in a given sample (or group) bin. These abnormal events lead to distortion of the measured correlation function. None of the existing correlator designs can filter these events in real time and at the fastest sampling frequency. Some techniques have implemented exclusion of abnormal counts by first detecting these events and then enabling electronic shutters to exclude these counts from being used in the accumulation of the correlation channels. However, these mitigatory techniques are necessarily several orders of magnitude slower than the fastest sampling rates of the correlator and not very effective. The present invention provides an electronic circuitry for abnormal event detection and exclusion of the momentary events from being a part of the correlation function at the fastest sampling rate, for example 25 ns, with no latency. Operation of the circuit is described below.
Continuing with reference to
After an initial set-up time equal to the maximum delay increment, all delay registers in the delay block 131 contains valid counts corresponding to nm. These register values are updated at the sampling clock rate. At the rising edge of each sample clock the counts in the delay registers are shifted into the multiplier/accumulator blocks 139 which compute the correlation function, according to the definition of Equation 1 for all delay increments M. These accumulations will continue until the end of the measurement signal (not shown), is received. A separate counter 140 accumulates the total counts ntotal 141 and another counter 142, in combination with the AND gate 143 accumulates the total number of valid samples Ns 144 used in the accumulation of the autocorrelation vector [G] 145.
Several data inversion methods for extracting physical information from the scattering system are in use. Invariably, all data inversion algorithms run on computers to extract the relevant information from the measured second order autocorrelation function. There exists a need for autonomous DLS systems with integrated hardware for direct inversion of the measured autocorrelation function.
The embodiment illustrated in
With reference to
The discrimination of abnormal counts takes place in real-time and at the fastest sampling interval. While the operation of the said the abnormal count sensor and discriminator has been described with reference to in vivo measurements from a human eye, it is appreciated that abnormal count sensor and discriminator 138 can also be used in other situations, for example, discrimination against deleterious signal due to the presence of large contaminant particles in a dilute suspension of small molecules. It should also be appreciated that the operation of the abnormal count sensor and discriminator 138 is independent of the counter depth, and an 8-bit counter is merely used to simplify the discussion herein.
Although illustrative embodiments of the present invention have been described herein with references to the accompanying drawings, it is to be understood that the invention is not limited to those precise embodiments, and that various other changes and modifications may be affected herein by one skilled in the art without departing from the scope or spirit of the invention.
This application claims the benefit of U.S. Provisional Patent Application No. 62/665,240, filed on May 1, 2018, the entire contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62665240 | May 2018 | US |